2013
DOI: 10.1016/j.antiviral.2013.08.016
|View full text |Cite
|
Sign up to set email alerts
|

Clinical management and infection control of SARS: Lessons learned

Abstract: The outbreak of severe acute respiratory syndrome (SARS) in 2003 was the first emergence of an important human pathogen in the 21st century. Responding to the epidemic provided clinicians with extensive experience in diagnosing and treating a novel respiratory viral disease. In this article, we review the experience of the SARS epidemic, focusing on measures taken to identify and isolate patients, prevent the transmission of infection to healthcare workers and develop effective therapies. Lessons learned from … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
129
0
3

Year Published

2014
2014
2020
2020

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 131 publications
(132 citation statements)
references
References 147 publications
0
129
0
3
Order By: Relevance
“…In a previous review, it was already mentioned that childhood vaccination will become one of the most important applications for disposable inhalers [9]. Also, protection or treatment programmes against threatening infections as, for instance, with H7N9 (bird flu) [87], Severe Acute Respiratory Syndrome (SARS) [88] or Middle East Respiratory Syndrome (MERS) viruses [89], immunisation against bioterrorism agents (e.g., anthrax, plague, tularaemia, botulism and smallpox) [90] or therapies against difficult to cure diseases like MDR and XDR TB [91] may in future be served best with disposable devices. Such applications often start or take place in developing countries with a warm climate where stable dry powders are preferred over wet formulations for reasons discussed in the introduction [92][93][94].…”
Section: Expert Opinionmentioning
confidence: 99%
“…In a previous review, it was already mentioned that childhood vaccination will become one of the most important applications for disposable inhalers [9]. Also, protection or treatment programmes against threatening infections as, for instance, with H7N9 (bird flu) [87], Severe Acute Respiratory Syndrome (SARS) [88] or Middle East Respiratory Syndrome (MERS) viruses [89], immunisation against bioterrorism agents (e.g., anthrax, plague, tularaemia, botulism and smallpox) [90] or therapies against difficult to cure diseases like MDR and XDR TB [91] may in future be served best with disposable devices. Such applications often start or take place in developing countries with a warm climate where stable dry powders are preferred over wet formulations for reasons discussed in the introduction [92][93][94].…”
Section: Expert Opinionmentioning
confidence: 99%
“…The estimated numbers of common HAI were approximately 93,300 cases of urinary tract infection and 157,500 cases of surgical site infection in 2011(Magill et al., ). In the recent largest outbreak of Middle East Respiratory Syndrome (MERS) in South Korea, Nature reported news on transmission between healthcare workers and patients (Butler, , ), similar to the case of the global spread of severe acute respiratory syndrome (SARS) during 2002–2003 (Chau et al., ; Cheng, Chan, To, & Yuen, ; World Health Organization, ). Visualization techniques using information technology such as infographics may increase awareness and mindfulness among nursing staff of patterns of infectious disease transmission in their workplaces.…”
mentioning
confidence: 91%
“…Currently it is unclear if there are additional asymptomatic cases of infection with MERS-CoV. MERS is reminiscent of the outbreak of severe acute respiratory syndrome (SARS) in the Guangdong province in China in 2002-2003 (reviewed in Cheng, Chan, To, & Yuen, 2013). …”
Section: - Introductionmentioning
confidence: 99%